Answers are grounded in this paper and cite their sources.
Stroke is a leading cause of death and long-term disability. Methylene blue, a drug grandfathered by the Food and Drug Administration with a long history of safe usage in humans for treating methemoglobinemia and cyanide poisoning, has recently been shown to be neuroprotective in neurodegenerative diseases and brain injuries. The goal of this paper is to review studies on methylene blue in experimental stroke models.
No takes yet. Share an insight, caveat, or question.
Zhao et al. (2016) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: